India's 2026 NDCT amendments: what actually changed vs what the headlines suggested.
Changed: pre-clinical manufacturing approval → prior intimation. BA/BE initiation. Review timeline 90 → 45 days.

#ClinicalTrials #India #CDSCO #NDCT2026 #RegulatoryStrategy #DrugDevelopment #Pharma #CRO